Claris Bio
Focus: Claris Bio is a public biotechnology company headquartered in Jersey City, NJ, focused on developing corneal disease therapies. The company operates at the intersection of oncology and ophthalmology.
Profile data last refreshed 32m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3+2 this month
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
Should You Work at Claris Bio?
AI assessmentClaris Bio may suit candidates seeking niche ophthalmology expertise and public-company stability, but severely limited pipeline transparency and hiring activity warrant caution.
Why Work Here
- Public company status provides equity liquidity and established governance structures rare in early-stage biotech.
- Specialized focus on corneal disease represents an underserved therapeutic niche with limited competition.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Claris Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.